Literature DB >> 8632264

The inflammatory response in pediatric biliary disease: macrophage phenotype and distribution.

T F Tracy1, P Dillon, E S Fox, K Minnick, C Vogler.   

Abstract

PURPOSE: Extrahepatic biliary obstruction in infants and children leads to ductal hyperplasia and portal fibrosis. Inflammatory mediators responsible for increased cellular proliferation and matrix deposition are hypothesized to result from the intrahepatic recruitment and activation of lymphocytes and macrophages (M phi). The authors previously showed components of this mechanism in studies that demonstrated increased adhesion molecule expression in biliary atresia, as well as evidence of altered hepatic M phi function during the course of experimental cholestatic liver injury. Therefore they sought determine the expression of macrophage receptor markers CD68 and CD14 in pediatric biliary disease.
METHODS: Sixteen liver specimens were snap-frozen and cryosectioned onto polylysine-coated slides. Sections were stained with murine monoclonal antibodies to CD68 (resident M phi) and CD14 (monocyte-M phi lipopolysaccharide [LPS] receptor) glycoproteins. The sections were analyzed using a semiquantitative scale of proliferation and were position-graded from 0 to 3 (maximal).
RESULTS: Blinded analysis showed that marked proliferation of CD68-positive cells occurred in five of the six patients with biliary atresia (BA) and in one patient who had severe cholestasis. Normal perisinusoidal liver M phi were found in specimens from patients with hepatitis (2), choledochal cyst (1), and congenital hepatic fibrosis (1). Similarly, expression of CD14 periportal M phi was found only in patients with BA or cholestasis (1.9 +/- 0.3 [mean +/- SEM]) and was absent in other diseases. Strong sinusoidal expression of CD14 was evident in all patients who had extrahepatic biliary obstruction. An early biopsy specimen from a premature infant with BA did not show cholestasis, fibrosis, CD68 Mø proliferation, or CD14 expression; however, another biopsy specimen, obtained further in the course of jaundice showed the progressive development of all features.
CONCLUSION: These findings suggest proliferation of resident M phi in association with cholestasis. The presence of the LPS receptor on periportal cells during cholestatic liver injury points to a potential source of cytokines responsible for the inflammatory reaction of biliary atresia.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8632264     DOI: 10.1016/s0022-3468(96)90333-4

Source DB:  PubMed          Journal:  J Pediatr Surg        ISSN: 0022-3468            Impact factor:   2.545


  21 in total

Review 1.  Biliary atresia: will blocking inflammation tame the disease?

Authors:  Kazuhiko Bessho; Jorge A Bezerra
Journal:  Annu Rev Med       Date:  2011       Impact factor: 13.739

Review 2.  Pathogenesis of biliary atresia: defining biology to understand clinical phenotypes.

Authors:  Akihiro Asai; Alexander Miethke; Jorge A Bezerra
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2015-05-26       Impact factor: 46.802

Review 3.  Biliary atresia: cellular dynamics and immune dysregulation.

Authors:  Amy G Feldman; Cara L Mack
Journal:  Semin Pediatr Surg       Date:  2012-08       Impact factor: 2.754

Review 4.  Clues to the etiology of bile duct injury in biliary atresia.

Authors:  Cara L Mack; Amy G Feldman; Ronald J Sokol
Journal:  Semin Liver Dis       Date:  2013-02-08       Impact factor: 6.115

5.  A comparison of gene expression in mouse liver and kidney in obstructive cholestasis utilizing high-density oligonucleotide microarray technology.

Authors:  Gerald U Denk; Shi-Ying Cai; Wen-Sheng Chen; Aiping Lin; Carol J Soroka; James L Boyer
Journal:  World J Gastroenterol       Date:  2006-04-28       Impact factor: 5.742

6.  Hepatic damage in biliary-obstructed rats is ameliorated by leflunomide treatment.

Authors:  Abdurrahman Karaman; Mustafa Iraz; Hale Kirimlioglu; Nese Karadag; Erkan Tas; Ersin Fadillioglu
Journal:  Pediatr Surg Int       Date:  2006-08-05       Impact factor: 1.827

7.  Cellular and humoral autoimmunity directed at bile duct epithelia in murine biliary atresia.

Authors:  Cara L Mack; Rebecca M Tucker; Brandy R Lu; Ronald J Sokol; Andrew P Fontenot; Yoshiyuki Ueno; Ronald G Gill
Journal:  Hepatology       Date:  2006-11       Impact factor: 17.425

8.  Expression of programmed death-1 and its ligands in the liver of biliary atresia.

Authors:  Pan-Liang Wang; Jun Wang; Ying Zhou; Xiao-Song Chen; Ke-Jun Zhou; Jie Wen; Jian-Jun Zhang; Wei Cai
Journal:  World J Pediatr       Date:  2017-03-22       Impact factor: 2.764

9.  Armed CD4+ Th1 effector cells and activated macrophages participate in bile duct injury in murine biliary atresia.

Authors:  Cara L Mack; Rebecca M Tucker; Ronald J Sokol; Brian L Kotzin
Journal:  Clin Immunol       Date:  2005-05       Impact factor: 3.969

10.  Contribution of hepatic parenchymal and nonparenchymal cells to hepatic fibrogenesis in biliary atresia.

Authors:  G A Ramm; V G Nair; K R Bridle; R W Shepherd; D H Crawford
Journal:  Am J Pathol       Date:  1998-08       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.